The Hyperandrogenic-Insulin-Resistant Acanthosis Nigricans Syndrome: Therapeutic Response

    March 1994 in “ Fertility and sterility ”
    Ricardo Azziz
    Image of study
    TLDR Most patients improved with oral contraceptives, but some needed additional treatment.
    The study investigated the therapeutic response of five women with hyperandrogenic-insulin-resistant acanthosis nigricans syndrome to oral contraceptives (OC) and spironolactone (SPA). After 6 months, four patients showed adequate suppression of free testosterone (T), increased sex hormone-binding globulin (SHBG) levels, and improved hair growth rate, with two also noting better hair texture. The fifth patient did not respond to OC therapy but showed significant improvement with GnRH-a suppression combined with hormonal replacement and SPA. The study concluded that while most patients respond well to OC treatment, GnRH-a suppression can be effective for those who do not. Hyperinsulinemia was found to enhance LH-stimulated androgen biosynthesis but could not sustain androgen production without sufficient gonadotropin stimulation.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 8 results

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Spironolactine Update: 2 months (34, Female)

      in Female  20 upvotes 7 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Reflex Hyperandrogenicty: How I recovered from it

      in Treatment 1 year ago
      The user experienced severe hair shedding from RU58841 and recovered by stopping its use and starting treatments including Minoxidil, Rosemary Verbenone, Stemoxydine, Aminexil, copper peptide serum, and specific shampoos. They also consistently used oral Finasteride and plan to try Minoxidil 10%.

      community HMI 115 Phase 2 - Leaked pics from Discord

      in Research/Science  366 upvotes 7 months ago
      The conversation discusses HMI 115, a new hair loss treatment with promising results, showing a significant increase in hair density after two months. Some users are skeptical, while others are hopeful for its release and potential affordability.

    Similar Research

    5 / 1000+ results
      Hirsutism: Diagnosis and Treatment

      research Hirsutism: Diagnosis and Treatment

      2 citations, January 2012 in “Journal of metabolic syndrome”
      The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.
      Androgen Excess: Investigations and Management

      research Androgen Excess: Investigations and Management

      82 citations, May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.
      Evidence-Based Approach to Cutaneous Hyperandrogenism in Women

      research Evidence-Based Approach to Cutaneous Hyperandrogenism in Women

      42 citations, July 2015 in “Journal of The American Academy of Dermatology”
      The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.